Clinical Trial Update: Adjuvant Concurrent Immunotherapy and Radiotherapy for the Treatment of Bladder Cancer [Phase 1]

View source ↗

Summary

This Phase 1 trial investigates adjuvant concurrent immunotherapy and radiotherapy for bladder cancer and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urothelial Carcinoma of the Bladder

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Urothelial Carcinoma Bladder, Bladder Cancer | Phase 1 | Status: RECRUITING